推薦產品
製造商/商標名
BP
drug control
estupefaciente (Spain); Decreto Lei 15/93: Tabela IA (Portugal)
尋找類似的產品? 前往 產品比較指南
一般說明
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.
應用
Codeine phosphate BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.
Also used in monographs such as:Paracetamol, Codeine Phosphate and Caffeine Capsules Co-dydramol Tablets Co-codamol Capsules Co-codamol Tablets Co-codamol Effervescent Tablets Paracetamol, Codeine Phosphate and Caffeine Tablets Morphine Tablets Morphine Prolonged-release Tablets Dihydrocodeine Prolonged-release Tablets Morphine Prolonged-release Capsules Morphine Granules for Oral Suspension Dihydrocodeine Oral Solution Co-codaprin Tablets Dihydrocodeine Injection Morphine Oral Solution Dihydrocodeine Tablets Morphine Suppositories Morphine Capsules Morphine Sulfate Injection Codeine Phosphate Oral Solution
Also used in monographs such as:
包裝
Unit quantity: 200 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia
其他說明
Sales restrictions may apply.
我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.
聯絡技術服務